Cargando…
Retracted: Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307375/ https://www.ncbi.nlm.nih.gov/pubmed/37387848 http://dx.doi.org/10.1155/2023/9826952 |
Ejemplares similares
-
Retracted: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)